What one share of Werewolf Therapeutics holds
We are an innovative biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body’s immune system for the treatment of cancer and other immune-mediated conditions. We are leveraging our proprietary PREDATOR platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional proinflammatory immune therapies.
Werewolf Therapeutics’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Profit | −$0.71 |
|---|---|
| Cash and investments | $0.45 |
| Debt | $0.66 |
| Book value | $0.34 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2020 | — | −$28.08 | $0.56 | −$19.09 | — | −$43.80 |
| 2021 | — | −$10.94 | $0.03 | −$2.35 | — | $5.59 |
| 2022 | — | −$1.86 | $0.13 | −$1.53 | — | $3.89 |
| 2023 | — | −$1.05 | $0.02 | −$0.94 | — | $2.85 |
| 2024 | — | −$1.63 | $0.01 | −$1.29 | — | $1.64 |
| 2025 | — | −$1.33 | $0.00 | −$1.29 | — | $0.51 |
Common questions about Werewolf Therapeutics
How much does one share of Werewolf Therapeutics earn?
Over the last 12 months, Werewolf Therapeutics lost $0.71 for each share.
Does Werewolf Therapeutics pay a dividend?
Werewolf Therapeutics didn’t pay a dividend over the last 12 months, according to its SEC filings.
What is Werewolf Therapeutics’s book value per share?
Werewolf Therapeutics’s book value is $0.34 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of June 30, 2026.
How much cash and debt does each share of Werewolf Therapeutics have?
Each share of Werewolf Therapeutics has $0.45 of cash and investments and $0.66 of debt, as of June 30, 2026.
Has Werewolf Therapeutics bought back shares?
Werewolf Therapeutics’s share count rose about 4558% from 2020 to 2025. That dilution means each share owns a smaller slice of the company.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.